Seattle, WA -- (SBWire) -- 10/03/2019 --A biosensor is an analytical device which is a combination of biological detecting elements such as a sensor system and a transducer. It is principally used to detect biological or chemical reactions generating signals proportional to the concentration of an analyte in the reaction.The two successful examples of biosensor device are pregnancy tests and glucose monitoring sensors. Technological advancement of biotechnology in terms of genetics, medicine, and bioinformatics is boosting the market growth of biosensor, which has enabled the opportunity for early diagnosis and improved treatment outcomes of various chronic disease such as diabetes and cancer. Moreover, point-of-care biosensor offers sensitive and rapid detection of target analytes, which is necessary for the diagnosis of disease such as cardiovascular, diabetes, and infectious disease such as cardiovascular disease, cancer, and infectious disease and it is also cost-effective option.

Rising prevalence of cardiovascular and diabetes disease coupled with the rising demand for cost-effective, user-friendly and disposable devices are the major factor fueling the market growth of the biosensor market. A biosensor is used by diabetic patients on a routine basis to monitor the blood sugar level as these devices offer easy monitoring and self-testing, hence supporting in diabetic management. According to the Global Diabetes Community, 2017, around 422 million adults are living with diabetes globally, where the number is expected to escalate to around 642 million by 2040. Also, according to the American Heart Association, 2016, cardiovascular diseases account for 17.3 million deaths every year globally, where an estimated 23.3 million people are expected to die from CVD by 2030, thus illustrating the rising need to adopt devices offering a timely diagnosis of craniological disorders.

Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/1647

Additionally, vendors and researchers are producing more advanced system such as real-time biosensor for providing instant result about health status, hence offering significant opportunities in improving personalized care devices. For instance, in 2016, VitalConnect, Inc. launched FDA approved Vital Connect platform to achieve better health and economic outcomes. The platform includes HealthPatch MD biosensor and the single-use VitalPatch biosensor. Also, in February 2018, Nanomedical Diagnostics launched Graphene Biosensor- FLEX, which can be easily integrated with company's Agile R100 protein assay system to increase the efficiency of the drug discovery process. Moreover, advanced biosensor such as wearable devices are cost-effective, affordable, and personalized healthcare monitoring devices which are widely used across commercial applications. Beside, advanced technology, the rising popularity of point-of-care diagnostic devices along with the growing application of biosensors in medical science are a major factor fueling the market growth of global biosensor market. Moreover, wearable biosensors have provided cost-effective, affordable, and personalized healthcare monitoring devices in various commercial applications. Furthermore, the advent of nanotechnology, chemistry, and medical science, and rising geriatric population base rate has fueled the growth of the global biosensors market. On the contrary, lack of awareness regarding the point-of-care diagnostic devices and high-cost associated with the wearable biosensor devices are projected to curb the market growth.

According to the Center for Advanced Life Cycle Engineering, University of Maryland, 2015, the treatment expenditure and loss of productivity is projected to be around US$ 790 billion and US$ 3.363 trillion, respectively in the U.S. in 2023. Various organization is adopting undertaking research activities to offer real-time alcohol monitoring devices, subjected to the rising cases of fatal associated with drunk and driving. For instance, in 2016, the University of California, San Diego, with funding from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), has created a wearable sensor that detects alcohol levels in perspiration and sends information to a smartphone. According to the Center of Disease Control and Prevention, around 88,000 people in the U.S. die every year from alcohol-related causes and according to the National Highway Traffic Safety Administration, over 9,900 people are killed in drunk driving crashes.

Key players in the global biosensors market are adopting novel strategies for launching innovative biosensors with enhanced product quality to cater to the demand of consumers for various types of biosensor products. For instance, in 2016, Profusa, Inc. received a US$ 7.5 Mn grant from Defense Advanced Research Projects Agency (DARPA) and the U.S. Army Research Office (ARO) to develop implantable biosensors for continuous monitoring of chemical constituents.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1647

Market Segmnetation

By Product Type

Wearable Devices

Non-wearable Devices

By Technology

Optical

Thermal

Electrochemical

Piezoelectric

Others

By Application

Drug Development

Medical Diagnosis

Research

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Some of the key players operating in the global biosensors market include Abbott Point of Care Inc., F. Hoffman-La Roche Ltd., Medtronic, Inc., Siemens AG, LifeScan, Inc., Acon Laboratories Inc., Universal Biosensors, Nova Biomedical Corp., Bio-Rad Laboratories Inc., Ercon, Inc., Biacore, and Sysmex Corporation.

To view the original version on The Express Wire visit https://www.coherentmarketinsights.com/ongoing-insight/biosensors-market-1647

About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.